Rheumatology

Your Article Summary

See Latest Articles

Newer therapies for vasculitis
Best Practice & Research: Clinical Rheumatology, 07/01/09

Hiemstra TF et al. - B-cell depletion with rituximab is currently attracting most attention with good success rates in small studies of refractory disease. The treatment of vasculitis in the future will become more complex with a wider range of available treatments; their optimal combination, sequencing and tailoring to the individual clinical situation will place unique demands on those delivering vasculitis services.

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Treatment of polymyalgia rheumatica
Archives of Internal Medicine, 11/10/09

Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09

Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09

See All of Clinical Pharmacology

Today in Vasculitic Syndromes...keeping you current

Receive free subspecialty "5-minute updates" via email

One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçets disease refractory to standard immunosuppressive drugs
Rheumatology International, 10/30/09

Vasculitis in Children and Adolescents: Clinical Presentation, Etiopathogenesis, and Treatment
Pediatric Drugs, 11/11/09

Management of acute coronary syndrome in a case of Behcets disease
Blood Coagulation & Fibrinolysis, 11/03/09

See All of Vasculitic Syndromes